血液腫瘍検査は血液疾患の診断、治療、予防であり、腫瘍学は癌の治療です。血液腫瘍学には、血友病、鉄欠乏性貧血、白血病およびリンパ腫、鎌状赤血球症、サラセミア、およびその他の臓器癌が含まれます。血液腫瘍検査市場は、血液癌の発生率の上昇や個別化治療の需要の増加などの要因により拡大しています。
2018年のPMC PubMed Centralによると、2018年に全米で約174,250人が相同性悪性腫瘍と診断されました。また、発生率は約129万人がHMと共存しています。 2020年の米国臨床腫瘍学会によると、半の推定数は、2020年の男性の679,412人よりも女性の方が多く、約712,758 です。一方、血液腫瘍診断のための高度な分子技術と、医薬品と診断の共同開発の増加により、市場に有利な機会が生まれています。ただし、不利な償還シナリオは、2022年から2029年の予測期間を通じて市場の成長を妨げます。
血液腫瘍検査の世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。血液癌の有病率の増加、高齢化の進展、先進的な治療法の認知度などから、売上高では北アメリカが圧倒的なシェアを占めています。一方、北アメリカは、白血病、リンパ腫、多発性骨髄腫の有病率の増加、予測期間中の市場関係者による研究開発活動の増加などの要因から、予測期間中に大きく成長すると予想されます。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Hemato Oncology Testing Market, by Region, 2019-2029 (USD Billion)
1.2.2. Hemato Oncology Testing Market, by Product & Service, 2019-2029 (USD Billion)
1.2.3. Hemato Oncology Testing Market, by Cancer Type, 2019-2029 (USD Billion)
1.2.4. Hemato Oncology Testing Market, by Technology, 2019-2029 (USD Billion)
1.2.5. Hemato Oncology Testing Market, by End-User, 2019-2029 (USD Billion)
1.2.6.
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Hemato Oncology Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Hemato Oncology Testing Market Dynamics
3.1. Hemato Oncology Testing Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising incidences of hematologic cancer
3.1.1.2. Increasing demand for personalized therapy
3.1.2. Market Challenges
3.1.2.1. Unfavorable Reimbursement Scenario
3.1.3. Market Opportunities
3.1.3.1. Rising advanced molecular techniques for hemato-oncology diagnostics
3.1.3.2. Increasing drug-diagnostics co-development
Chapter 4. Global Hemato Oncology Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre-COVID-19D-19 and post-COVID-19 Market scenario
Chapter 6. Global Hemato Oncology Testing Market, by Product & Service,
6.1. Market Snapshot
6.2. Global Hemato Oncology Testing Market by Product & Service, Performance - Potential Analysis
6.3. Global Hemato Oncology Testing Market Estimates & Forecasts by Product & Service, 2019-2029 (USD Billion)
6.4. Hemato Oncology Testing Market, Sub-Segment Analysis
6.4.1. Assay Kits,
6.4.2. Services
Chapter 7. Global Hemato Oncology Testing Market, by Cancer Type
7.1. Market Snapshot
7.2. Global Hemato Oncology Testing Market by Cancer Type, Performance - Potential Analysis
7.3. Global Hemato Oncology Testing Market Estimates & Forecasts by Cancer Type 2019-2029 (USD Billion)
7.4. Hemato Oncology Testing Market, Sub Segment Analysis
7.4.1. Leukemia
7.4.2. Non-Hodgkin’s Lymphoma
Chapter 8. Global Hemato Oncology Testing Market, by Technology,
8.1. Market Snapshot
8.2. Global Hemato Oncology Testing Market by Technology, Performance - Potential Analysis
8.3. Global Hemato Oncology Testing Market Estimates & Forecasts by Technology, 2019-2029 (USD Billion)
8.4. Hemato Oncology Testing Market, Sub Segment Analysis
8.4.1. PCR, Polymerase chain reaction
8.4.2. NGS, Next-generation sequencing (NGS)
8.4.3. IHC Immunohistochemistry (IHC)
Chapter 9. Global Hemato Oncology Testing Market, by End-User
9.1. Market Snapshot
9.2. Global Hemato Oncology Testing Market by End-User, Performance - Potential Analysis
9.3. Global Hemato Oncology Testing Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
9.4. Hemato Oncology Testing Market, Sub Segment Analysis
9.4.1. Clinical Laboratories,
9.4.2. Hospitals
Chapter 10. Global Hemato Oncology Testing Market, Regional Analysis
10.1. Hemato Oncology Testing Market, Regional Market Snapshot
10.2. North America Hemato Oncology Testing Market
10.2.1. U.S. Hemato Oncology Testing Market
10.2.1.1. Product & Services breakdown estimates & forecasts, 2019-2029
10.2.1.2. Cancer Type breakdown estimates & forecasts, 2019-2029
10.2.1.3. Technology breakdown estimates & forecasts, 2019-2029
10.2.1.4. End-User breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Hemato Oncology Testing Market
10.3. Europe Hemato Oncology Testing Market Snapshot
10.3.1. U.K. Hemato Oncology Testing Market
10.3.2. Germany Hemato Oncology Testing Market
10.3.3. France Hemato Oncology Testing Market
10.3.4. Spain Hemato Oncology Testing Market
10.3.5. Italy Hemato Oncology Testing Market
10.3.6. Rest of Europe Hemato Oncology Testing Market
10.4. Asia-Pacific Hemato Oncology Testing Market Snapshot
10.4.1. China Hemato Oncology Testing Market
10.4.2. India Hemato Oncology Testing Market
10.4.3. Japan Hemato Oncology Testing Market
10.4.4. Australia Hemato Oncology Testing Market
10.4.5. South Korea Hemato Oncology Testing Market
10.4.6. Rest of Asia Pacific Hemato Oncology Testing Market
10.5. Latin America Hemato Oncology Testing Market Snapshot
10.5.1. Brazil Hemato Oncology Testing Market
10.5.2. Mexico Hemato Oncology Testing Market
10.6. Rest of The World Hemato Oncology Testing Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. F. Hoffmann-La Roche Ltd
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Abbott
11.2.3. Invitae Corporation (Archerdx, Inc)
11.2.4. QIAGEN
11.2.5. Thermo Fisher Scientific Inc.
11.2.6. Illumina Inc.
11.2.7. Bio-Rad Laboratories, Inc.-
11.2.8. Molecularmd (Subsidiary of Icon PLC)
11.2.9. Asuragen, Inc.
11.2.10. Arup Laboratories Inc.
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
List of Tables
TABLE 1. Global Hemato Oncology Testing Market, report scope
TABLE 2. Global Hemato Oncology Testing Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Hemato Oncology Testing Market estimates & forecasts by Product & Services 2019-2029 (USD Billion)
TABLE 4. Global Hemato Oncology Testing Market estimates & forecasts by Cancer Type 2019-2029 (USD Billion)
TABLE 5. Global Hemato Oncology Testing Market estimates & forecasts by Technology 2019-2029 (USD Billion)
TABLE 6. Global Hemato Oncology Testing Market estimates & forecasts by End-User 2019-2029 (USD Billion)
TABLE 7. Global Hemato Oncology Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Hemato Oncology Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Hemato Oncology Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Hemato Oncology Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Hemato Oncology Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Hemato Oncology Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Hemato Oncology Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Hemato Oncology Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Hemato Oncology Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Hemato Oncology Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Hemato Oncology Testing Market
TABLE 72. List of primary sources, used in the study of global Hemato Oncology Testing Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Hemato Oncology Testing Market, research methodology
FIG 2. Global Hemato Oncology Testing Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Hemato Oncology Testing Market, key trends 2021
FIG 5. Global Hemato Oncology Testing Market, growth prospects 2022-2029
FIG 6. Global Hemato Oncology Testing Market, porters 5 force model
FIG 7. Global Hemato Oncology Testing Market, pest analysis
FIG 8. Global Hemato Oncology Testing Market, value chain analysis
FIG 9. Global Hemato Oncology Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Hemato Oncology Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Hemato Oncology Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Hemato Oncology Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Hemato Oncology Testing Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Hemato Oncology Testing Market, regional snapshot 2019 & 2029
FIG 15. North America Hemato Oncology Testing Market 2019 & 2029 (USD Billion)
FIG 16. Europe Hemato Oncology Testing Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Hemato Oncology Testing Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Hemato Oncology Testing Market 2019 & 2029 (USD Billion)
FIG 19. Global Hemato Oncology Testing Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
